Business WireFDA Grants Priority Review for Immunotherapy-Based Lung Cancer CombinationCuretoday.com“Keytruda is the first immunotherapy to significantly extend survival of patients with nonsquamous non–small cell lung cancer in combination with chemot… Continue reading
PR Newswire (press release)Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy …GlobeNewswire (press release)CAMBRIDGE, Mass., April 30, 2018 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (… Continue reading
PR Newswire (press release)Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy …GlobeNewswire (press release)CAMBRIDGE, Mass., April 30, 2018 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (… Continue reading
MedscapeImmunotherapy Combinations Show Promise for Blood CancersMedscapeClinical trials with immunotherapy combinations are expanding rapidly, and it is easy to envision profound antitumor effects. Unlike the incremental improvements in progression-fr… Continue reading
EurekAlert (press release) |
T cell biomarker predicts which CLL patients will respond to CAR T cell therapy
EurekAlert (press release) PHILADELPHIA – Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia (CLL) don’t respond to chimeric antigen receptor (CAR) T cell therapy, and the answer is tied to how primed patients’ immune … |